Resources-Oriented Salutogenic (ROS) Intervention for Pre-diabetes
NCT06515119
Summary
This pilot randomized control trial (RCT) is to assess whether the newly developed resources-oriented intervention is feasible and acceptable to people with pre-diabetes and has preliminary efficacy on sense of coherence (SoC). The research questions are: 1. What are the key components (available resources and their utilization skills) of Resources-Oriented Salutogenic intervention in Chinese pre-diabetes population? 2. What are the feasibility and acceptability of ROS intervention among pre-diabetes population in China? 3. What is the preliminary efficacy of ROS intervention on improving sense of coherence, coping strategies, perceived stress, health literacy, and HbA1c on Chinese pre-diabetes population?
Eligibility
Inclusion Criteria: Subjects are those with pre-diabetes and low or moderate level of sense of coherence. 1. prediabetes diagnosis: Pre-diabetes app score \>= 8, considered as 'pre-diabetes' or 'at high-risk of diabetes'; then, HbA1c test result within 5.7% to 6.4% will be diagnosed as prediabetes. 2. low or moderate SoC level: SoC-13 scale score \<= 74. 3. Chinese (Mandarin or Cantonese) or English and live in China, 4. could use Facebook and Zoom meeting app. Exclusion Criteria: Participants will be excluded if they: 1. have a history of diabetes, using hypoglycemic drugs, pregnancy, lactation, disability, or other physical limitations; 2. presence of serious health complications might affect the HbA1c level such as anemia, renal failure, liver disease; 3. participation in a similar intervention program within 3 months focusing on diabetes prevention in the past three months including educational workshops or courses, nutritional program, exercise program or mental health intervention.
Conditions4
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06515119